外泌体miRNA生物标志物在肝癌中的研究进展*

外泌体广泛存在于多种体液中,携带有大量活性物质,如mRNA、miRNA、蛋白和脂质等。其中的miRNA是一类短非编码RNA,在转录后水平调节基因的表达,广泛参与个体生长发育等各生命活动。外泌体miRNA有多种生物学功能,在肿瘤的发生发展、侵袭转移、机体耐药及免疫调控等多方面发挥着重要作用。目前的研究表明,无论是作为肿瘤早筛早诊和预后评估标志物还是用于肿瘤治疗,外泌体miRNA都有很好的应用前景。本文就近年来外泌体miRNA在肝癌中的研究进展和临床应用进行综述。     

人源microRNA分子表达库的构建

microRNA(miRNA)是一类长度为22nt左右的单链非编码小RNA分子,通过与靶mRNA分子结合而沉默其表达.目前,虽然在多种生物中发现了大量的miRNA,但对它们的功能还知之甚少.为了深入研究miRNA的功能,构建了一个包括170多种人源miRNA表达载体的miRNA分子表达库,并对部分表达载体采用RNA印迹及双荧光素酶分析技术进行验证.实验证明:这些miRNA表达载体在HEK-293细胞内可以高水平表达miRNA前体和成熟的miRNA,并且能抑制含有相应靶位点的报告基因的表达.这些结果表明:该miRNA表达库可以表达功能miRNA,并可用于miRNA功能的筛选和研究.     

哺乳动物的miRNA研究

微小RNA(microRNA,miRNA)是新近发现的一类重要非编码调控RNA,以转录或转录后水平调节方式参与哺乳动物发育(细胞生长、分化、凋亡)、免疫调节及疾病发生等过程。就miRNA的形成及作用机制,哺乳动物中miRNA发现策略、靶位点的识别,miRNA功能研究进行综述,为类似研究提供参考。     

miRNA功能的研究进展

综述了miRNA功能的最新研究进展。miRNA是一类长度约20~24nt的非编码调控单链小分子RNA,其功能和作用是近年来分子生物学界关注的重点。这些微小的RNA控制着包括细胞增殖、凋亡、器官发生、发育、造血以及肿瘤发生等若干途径。最近研究发现,miRNA可能同时具有肿瘤抑制因子和源癌基因的功能,并且可能在癌症的诊断和治疗中发挥重要的作用。miRNA可以通过影响或者调控细胞增殖、分化过程中的信使RNA和关键蛋白质等参与细胞的发育。此外,miRNA对多种植物激素的调控作用对于植物体的发育也具有重要意义。     

Role of miRNA and miRNA processing factors in development and disease

Mature microRNAs (miRNAs) are single-stranded RNA molecules of 17-24 nucleotides (nt) in length that are encoded in the genomes of plants and animals. The seminal discoveries of miRNA made in C. elegans have led the way to the rampant discoveries being made today in this field. Since each miRNA is predicted and in some cases confirmed to regulate multiple genes, the potential regulatory circuitry afforded by miRNAs is thought to be enormous and could amount to regulation of >30% of all human genes. Due to the sequences of many of the miRNAs being highly homologous among organisms, the huge potential of miRNAs to regulate gene expression, and the hints of miRNAs being useful in both diagnostics and therapeutics, it is no wonder these small RNAs are gaining such popularity in both the academic and industrial settings. It is now becoming clear that the miRNA gene class represents a very important gene regulatory network. This article reviews the initial discoveries of miRNA that began in the nematode C. elegans, and extends into what is known about miRNAs and miRNA processing factors in mouse development and human disease.     

MiRNA:一种新的基因表达调节子

在动植物基因组中广泛存在一类非编码蛋白的RNA基因,产生长度大约为21～24个核苷酸的RNA,它们被命名为microRNA（miRNA）。 这是一类具有调节其他基因表达活性的小RNA。在生物的发育过程中发挥着重要作用。本文对这种基因表达调节途径的发现、机制功能及研究方法和现状作简要概述。 Abstract:Plant and animal genomes contain an abundance of small genes that produce RNAs of about 22 nucleotides in length, which was dubbed as microRNAs.These newly found endogenous RNAs may participate in a wide range of genetic regulatory pathways and play an important role in the development.This paper is focused on the finding of the microRNAs,its mechanism and function,as well as the methods of research.     

The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease

Recent studies have established that mutations or deletions in microRNA (miRNA) processing enzymes resulting in a global decrease of miRNA expression are frequent across cancers and can be associated with a poorer prognosis. While very popular in miRNA profiling studies, it remains unclear whether miRNA microarrays are suited or not to accurately detecting global miRNA decreases seen in cancers. In this work, we analyzed the miRNA profiles of samples with global miRNA decreases using Affymetrix miRNA microarrays following the inducible genetic deletion of Dicer1. Surprisingly, up to a third of deregulated miRNAs identified upon Dicer1 depletion were found to be up-regulated following standard robust multichip average (RMA) background correction and quantile normalization, indicative of normalization bias. Our comparisons of five preprocess steps performed at the probe level demonstrated that the use of cyclic loess relying on non-miRNA small RNAs present on the Affymetrix platform significantly improved specificity and sensitivity of detection of decreased miRNAs. These findings were validated in samples from patients with prostate cancer, where conjugation of robust normal-exponential background correction with cyclic loess normalization and array weights correctly identified the greatest number of decreased miRNAs, and the lowest amount of false-positive up-regulated miRNAs. These findings highlight the importance of miRNA microarray normalization for the detection of miRNAs that are truly differentially expressed and suggest that the use of cyclic loess based on non-miRNA small RNAs can help to improve the sensitivity and specificity of miRNA profiling in cancer samples with global miRNA decrease.     

Genome-wide miRNA signatures of human longevity

Little is known about the functions of miRNAs in human longevity. Here, we present the first genome-wide miRNA study in long-lived individuals (LLI) who are considered a model for healthy aging. Using a microarray with 863 miRNAs, we compared the expression profiles obtained from blood samples of 15 centenarians and nonagenarians (mean age 96.4 years) with those of 55 younger individuals (mean age 45.9 years). Eighty miRNAs showed aging-associated expression changes, with 16 miRNAs being up-regulated and 64 down-regulated in the LLI relative to the younger probands. Seven of the eight selected aging-related biomarkers were technically validated using quantitative RT-PCR, confirming the microarray data. Three of the eight miRNAs were further investigated in independent samples of 15 LLI and 17 younger participants (mean age 101.5 and 36.9 years, respectively). Our screening confirmed previously published miRNAs of human aging, thus reflecting the utility of the applied approach. The hierarchical clustering analysis of the miRNA microarray expression data revealed a distinct separation between the LLI and the younger controls (P-value < 10(-5) ). The down-regulated miRNAs appeared as a cluster and were more often reported in the context of diseases than the up-regulated miRNAs. Moreover, many of the differentially regulated miRNAs are known to exhibit contrasting expression patterns in major age-related diseases. Further in silico analyses showed enrichment of potential targets of the down-regulated miRNAs in p53 and other cancer pathways. Altogether, synchronized miRNA-p53 activities could be involved in the prevention of tumorigenesis and the maintenance of genomic integrity during aging.     

SNPs in human miRNA genes affect biogenesis and function

MicroRNAs (miRNAs) are 21–25-nucleotide-long, noncoding RNAs that are involved in translational regulation. Most miRNAs derive from a two-step sequential processing: the generation of pre-miRNA from pri-miRNA by the Drosha/DGCR8 complex in the nucleus, and the generation of mature miRNAs from pre-miRNAs by the Dicer/TRBP complex in the cytoplasm. Sequence variation around the processing sites, and sequence variations in the mature miRNA, especially the seed sequence, may have profound affects on miRNA biogenesis and function. In the context of analyzing the roles of miRNAs in Schizophrenia and Autism, we defined at least 24 human X-linked miRNA variants. Functional assays were developed and performed on these variants. In this study we investigate the affects of single nucleotide polymorphisms (SNPs) on the generation of mature miRNAs and their function, and report that naturally occurring SNPs can impair or enhance miRNA processing as well as alter the sites of processing. Since miRNAs are small functional units, single base changes in both the precursor elements as well as the mature miRNA sequence may drive the evolution of new microRNAs by altering their biological function. Finally, the miRNAs examined in this study are X-linked, suggesting that the mutant alleles could be determinants in the etiology of diseases.     

Insights into miRNA regulation of the human glycome

Glycosylation is an intricate process requiring the coordinated action of multiple proteins, including glycosyltransferases, glycosidases, sugar nucleotide transporters and trafficking proteins. Work by several groups points to a role for microRNA (miRNA) in controlling the levels of specific glycosyltransferases involved in cancer, neural migration and osteoblast formation. Recent work in our laboratory suggests that miRNA are a principal regulator of the glycome, translating genomic information into the glycocode through tuning of enzyme levels. Herein we overlay predicted miRNA regulation of glycosylation related genes (glycogenes) onto maps of the common N-linked and O-linked glycan biosynthetic pathways to identify key regulatory nodes of the glycome. Our analysis provides insights into glycan regulation and suggests that at the regulatory level, glycogenes are non-redundant.     

miRNA与涡虫再生

miRNA是一类具有调节功能的非编码小分子RNA,参与调节多种细胞功能。涡虫具有强大的再生能力,逐渐成为干细胞功能和再生研究的良好的动物模型。本文对miRNA在动物再生中的功能,尤其是miRNA与涡虫再生的关系进行综述。     

Improvement of a miRNA inhibitor by intracellular selection

ABSTRACT

Sequences surrounding the miRNA binding domain of the miRNA inhibitor LidNA were selected intracellularly. The library was transfected into cells, and then, inhibitors that were associated with argonaute 2 were selected. The potent inhibitors were slowly degraded intracellularly, while the lower-activity inhibitors were rapidly degraded. A combination of the selected sequences surrounding the miRNA binding domain enhanced miRNA inhibitory activity.     

干扰小RNA与微RNA

干扰小RNA（small interfering RNA;siRNA）和微RNA（microRNA;miRNA）是两种序列特异性地转录后基因表达的调节因子,它们的相关性密切,既具有相似性,又具有差异性。该文主要介绍这两种小RNA分子的产生、作用机制,以及两者之间的联系与区别。     

MiRNA在特发性肺纤维化中的作用

近年来研究发现微RNA（microRNA,miRNA）与机体人部分生理、病理过程均有密切关系,如：组织的发育和分化、组织再生、病毒防御以及细胞增殖与凋亡等。miRNA在特发性肺纤维化（IPF）中的作用也日渐为研究者所重视,在IPF中有些miRNA上调（如miR-155、miR-21）,有些下调（如let-7、miR-29、miR-200）。这一发现为寻找IPF治疗方法提供了一个新的突破口。本文对近年来miRNA在IPF中作用的研究进展进行了综述,并对miRNA-21、let-7d、miRNA-155、miRNA-29以及miRNA-200在肺纤维化中的作用分别进行了阐述,为研究miRNA征IPF中的作用及机制提供一定参考。     

microRNA在人类免疫缺陷病毒感染中的作用

microRNA(miRNA)对调控基因表达有着重要作用,病毒与宿主在miRNA水平存在着复杂的"对话"。研究显示,人类免疫缺陷病毒(HIV)可能编码病毒miRNA(vmiRNA),通过维持病毒潜伏、保护感染细胞免于凋亡或外力刺激下的细胞死亡等方式,在HIV病理过程中发挥重要作用。宿主miRNA则参与到了抗HIV的防御性机制中,但也面临HIV调控相应宿主miRNA、编码RNA沉默抑制物等多种阻力。深入研究HIV与宿主间miRNA水平上的动态相互作用,有助于进一步了解HIV的致病机理,开发新的治疗策略。     

Intra-individual variation of miRNA expression levels in human plasma samples

Background: Circulating miRNAs as potential non-invasive biomarkers for disease risk assessment and cancer early diagnosis have attracted increasing interest. Little information, however, is available regarding the intra-individual variation of circulating miRNA levels.

Methods: We measured expression levels of a panel of 800 miRNAs in repeated plasma samples from 51 healthy individuals that were collected 6 to 12?months apart and evaluated the intra-individual variation by the intra-class correlation coefficient (ICC).

Results: After background correction, a total of 185 miRNAs were detected in at least 10% of the plasma samples, with 69 and 28 miRNAs being detected in 50% and 90% of samples, respectively. The median ICC was 0.46 for these 185 miRNAs. Among them, 41% (75 miRNAs) had an ICC?≥?0.5, and 23% (42 miRNAs) had an ICC?≥?0.6. The ICC is higher for miRNAs with higher expression levels or higher detection rates, when compared to those with lower expression levels or lower detection rates.

Conclusions: These results suggest that common circulating miRNAs are stable over a relatively long period and can serve as reliable biomarkers for epidemiological and clinical research.     

靶向miRNA前体不同类型sgRNA的丰度及特异性评估

CRISPR/Cas技术能高效进行基因组定点编辑,但不同细菌来源或人工改造的Cas9以及Cpf1等核酸酶识别的PAM (protospacer adjacent motif)有差异,因此不同的基因编辑核酸酶可能采用不同类型的sgRNAs(small guide RNAs)。MicroRNAs (miRNAs)是一类调控性的小分子非编码RNAs,为了研究miRNA前体中是否可能存在特异性高的sgRNAs靶点,本文利用本课题组前期开发的生物信息学软件CRISPR-offinder,对靶向28 645条miRNA前体的11种不同类型sgRNA的丰度及特异性进行了分析,并利用CRISPR/Cas9慢病毒技术构建了猪miR-302/367基因簇敲除细胞系,对构建的猪miRNA敲除细胞系的效率进行了检测。结果表明,每个miRNA前体中平均存在约8种不同类型sgRNA的靶点;通过评估靶向猪miRNA前体sgRNA的脱靶效应,发现其中特异性高的sgRNA仅占18.2%;通过CRISPR/Cas9慢病毒技术成功构建了猪miR-302/367基因簇敲除细胞系,发现通过该技术构建miRNA敲除细胞系的效率为40%。本研究为利用CRISPR/Cas技术靶向敲除miRNA提供了重要资源。